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Abstract
Background: Factor V deficiency is a rare autosomal recessive coagulation disorder. Awareness
of presenting features and management is important to avoid bleeding complications associated
with mortality and neurodisability.
Case presentation: A 6-day-old Pakistani boy was admitted with bleeding from the left nipple.
His parents were first cousins. A coagulation screen showed a prothrombin time of 41 s (control
14 s), a partial thromboplastin time of 132 s (control 33 s) and a normal thrombin time of 15 s
(control 14 s). Factor V activity was <0.01 IU/ml. Oral tranexamic acid was started. At 5 weeks of
age the child presented with irritability, lethargy and reduced feeding and a drop of hemoglobin to
5.6 g/dl. A cranial computed tomography scan showed a right intra-cerebral bleed extending from
the frontal lobe to the parieto-occipital region with shift of the midline to the left. A regime of 20
ml/kg of fresh frozen plasma four times a week was instituted and has prevented further bleeds up
to the present age of 21 months. Neurodevelopment remained normal.
Conclusion: This case illustrates that in an unusually bleeding newborn of consanguineous parents
rare severe homozygous bleeding disorders need to be considered. Nipple bleeding may be the
first presentation of a congenital bleeding disorder. In cases of factor V deficiency where factor
concentrates are not available long term use of fresh frozen plasma can prevent potentially life
threatening bleeding.
Background
Congenital deficiency of factor V (labile factor, proaccel-
erin) is a rare hereditary coagulation disorder with an inci-
dence of 1:1000,000 and is inherited as an autosomal
recessive trait [1]. The active form of coagulation factor V
is involved as an essential non-enzymatic cofactor for the
activated factor X catalysed conversion of prothrombin to
thrombin. Affected patients become symptomatic in early
childhood with spontaneous or post-traumatic bleeding
complications [2]. We present to our knowledge the first
case of nipple bleeding as the initial hemorrhagic mani-
festation of factor V deficiency in the neonatal period. It
preceded an intracerebral hemorrhage.
Case presentation
A 6-day-old Pakistani boy was admitted to hospital in
June 2005 for bleeding from the left nipple. His parents
are first cousins. He has two siblings aged 8 and 6 years.
There was no family history of bleeding diathesis. The
mother had a normal pregnancy with full antenatal care.
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Mode of delivery at term was an elective Caesarean section
due to previous Caesarean sections. His birth weight was
2.7 kg. 1 mg of Vitamin K was given intramuscularly at
delivery. His first neonatal check was normal. He had a
small amount of self-limiting bleeding from the umbilical
cord on day 3 of life. He went home on day 4.
On day 6 of life he had mild spontaneous left sided nipple
bleeding, which presented as spots of blood stains on the
left side of his baby dress.
Over the next 7 days he had two further episodes of a sim-
ilar nature. Baseline biochemistry and full blood count
were normal but a coagulation screen showed a pro-
longed prothrombin time of 41 s (control 14 s), a pro-
longed partial thromboplastin time of 132 s (control 33 s)
and normal thrombin time of 15 s (control 14 s). In view
of the mild nature of bleeding, the child was only treated
with 1 mg of i.v. vitamin K. Subsequent coagulation
assays revealed a plasma factor V activity of less than 0.01
IU/ml (normal range 0.50–1.50 IU/ml) determined by
factor V clotting assay with all other coagulation factors in
the normal range. Hence the diagnosis of congenital fac-
tor V deficiency was made. A cerebral ultrasound done at
this stage was within normal limits. Oral transexamic acid
at a dose of 15 mg/kg/dose 3 times daily was started.
Mother was found to have a plasma factor V activity of
0.44 IU/ml (normal range 0.5–1.50 IU/ml) and the father
of 0.52 IU/ml by factor V clotting assay. Both levels are
compatible with heterozygous factor V deficiency. The sib-
lings had factor V activities of 0.61 and 1.1 IU/ml respec-
tively. Genetic analysis at the St. Thomas Hospital
hemophilia molecular genetics laboratory showed that
the affected child is homozygous for a frame shift muta-
tion resulting in a premature termination sequence at
codon 2178 in exon 25 of the factor V gene and both par-
ents are heterozygous for this mutation.
The infant presented at day 15 of age with a further epi-
sode of bleeding from the umbilical stump. The bleeding
stopped promptly following administration of 20 ml/kg
of fresh frozen plasma (FFP, methyleneblue sterilized, sin-
gle donor and US sourced). Small bruises were noted
around the venepuncture sites from the previous admis-
sion. A hematoma measuring 2 cm in diameter was noted
on the anterolateral aspect of the left thigh. It was attrib-
uted to the injection of vitamin K at birth. His head cir-
cumference was increasing within normal range and a
repeat cerebral ultrasound was normal.
The patient presented again at 5 weeks of age with pallor,
irritability, lethargy and reduced feeding. His anterior fon-
tanelle was bulging and tense. He was hemodynamically
stable. His hemoglobin was 5.6 g/dl, which represented a
significant drop from the previous estimation 3 weeks
back. The cerebral ultrasound was repeated and showed a
large intracerebral hemorrhage extending from the frontal
lobe to the parieto-occipital region. There were a few cystic
areas seen within this bleed, which suggested that the
bleeding started at least a few weeks ago. The child was
immediately transfused with 20 ml/kg of FFP and 15 ml/
kg of packed red blood cells. He had a series of generalized
fits within 5 hours of admission. The patient was trans-
ferred to the regional tertiary referral centre for specialised
neurosurgical and haematological management. A cranial
computed tomography (CT) scan showed a right, large,
intracerebral bleed causing a shift of the midline to the
left. The ventricles were not enlarged and the bleed did
not extend into the ventricles (See Figure 1). A Hickman
line insertion was arranged to enable regular FFP infu-
sions. Preoperatively he was transfused again with 20 ml/
kg FFP and 10 ml/kg of platelet concentrate to achieve
adequate hemostasis. Platelets are known to be a good
source of factor V as it is stored in the platelet alpha gran-
ules. He was also given recombinant factor VIIa (Novo-
seven, NovoNordisk®) as an empirical adjunctive agent in
the peri-operative period in view of the fact that reliably
hemostatic levels of factor V (0.25–0.30 IU/ml) are diffi-
cult to achieve in this condition. Factor VIIa is unlikely to
work in the absence of any factor V but can contribute to
increased thrombin formation once factor V is present.
Postoperatively a regime of FFP (15 ml/kg/dose) adminis-
tration was set up: FFP twice a day for the first 10 days fol-
lowed by once a day for the next 10 days. This was
followed by at least alternate days (every 48 hours) of FFP
at 20 ml/kg/day up to the present. Plasma factor V activity
has been monitored: A maximum factor V level of 0.23
IU/ml was achieved within 20 minutes after transfusion.
Trough levels were between <0.01 to 0.05 IU/ml. When
undetectable factor V levels were noted inhibitor assays
were performed. Inhibitors have not been detected so far.
No further bleeding has been noted up to the present day.
Immunisations including hepatitis B vaccination were
given subcutaneously as is normal practice for children
with severe bleeding disorders. Follow up until the
present (21 months of age) revealed an appropriate incre-
ment in head circumference. Neurodevelopment has been
within normal limits.
Conclusion
Our report describes the 6th case of homozygous severe
factor V deficiency presenting as bleeding in the early neo-
natal period reported in the English literature. Clinical
and laboratory features of the other cases [1-5] are listed
in Table 1. Unilateral nipple bleeding as the first signifi-
cant bleeding manifestation has not been reported in a
coagulation disorder before. The differential diagnosis of
nipple bleeding in infancy includes trauma, infection or
spontaneous bleeding of a hypertrophic (due to maternalBMC Pediatrics 2007, 7:8 http://www.biomedcentral.com/1471-2431/7/8
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hormones like estrogen, progesterone and prolactin)
breast gland [6], papillomas within the breast gland [7]
and infantile cystic ductal hyperplasia of the breast gland
[8]. In our case there were no clinical features supporting
any of these diagnoses. Mild hemorrhagic manifestations
of coagulation disorders in infants reported previously
included umbilical stump bleeding, subcutaneous
hematomas, epistaxis and gum bleeding [9]. This case
illustrates that in an unusually bleeding newborn of con-
sanguineous parents rare severe homozygous bleeding
disorders need to be considered. The mild first manifesta-
tions need to alert the clinician and lead to the prompt
initiation of coagulation studies bearing in mind that in
factor XIII deficiency coagulation tests are normal and fac-
tor analysis is required. Even though factor V deficiency
can be recognized early prophylaxis of bleeding complica-
tions like intracerebral bleeds is difficult in the absence of
a factor concentrate and in view of the fact that the risk of
intracerebral bleeds for the individual patient is
unknown. Intracerebral or subdural bleeds are the most
feared complication and have been noted in about 1/10
reported cases in the neonatal period which may be an
overestimate due to overreporting [4]. In our case, a life
threatening intracerebral bleed occurred at 5 weeks of age.
Though rare, congenital factor V deficiency should be kept
in mind as a differential diagnosis in an otherwise well
term infant presenting with catastrophic intracranial
bleed, particularly if the parents are consanguineous [2].
Prolonged PT and PTT with normal thrombin time and
normal platelet count would be an initial pointer towards
an inherited disorder of coagulation. Clotting factor assay
revealing markedly reduced plasma factor V activity con-
firms the diagnosis [4]. As there is no specific concentrate
available, the mainstay of treatment for severe factor V
deficiency is FFP. Platelets also contain factor V, though
their use should be reserved for life threatening bleeding
and prior to surgery. There is a considerable variation in
the volume of FFP and frequency of its administration
needed to achieve hemostasis for a particular bleeding
episode in the individual patient [4,10]. FFP administra-
tion should be titrated according to estimated changes in
the plasma factor V activity [5]. The half-life of factor V is
12–36 hours and is probably lower in neonates. Therefore
regular infusions at least every 48 hours are required in
patients with a history of severe bleeding complications.
Despite such a regime it is difficult to achieve a factor V
level >0.3 IU/ml without encountering problems of fluid
overload because of the fact that FFP is not a concentrated
treatment.
In our patient one could argue that early institution of reg-
ular FFP infusions could have prevented the intracranial
hemorrhage but it is crucial to establish in each case that
they have a severe bleeding phenotype before embarking
on regular FFP infusions, which carry the risks associated
with central venous access and FFP and platelet transfu-
sion. Many reported cases of severe factor V deficiency did
not have such severe bleeds and only needed treatment at
times of surgical challenge [11,12]. At present it is difficult
to predict the clinical course with regards to the risk of
severe bleeding complications. Future genetic studies may
improve our understanding of the risk of developing a
severe phenotype associated with a specific genotype. As
severe factor V deficiency with a clinically severe pheno-
type is a very rare disorder of hemostasis the long term
prognosis cannot be delineated. It is very likely that cases
such as this did not survive infancy in the past and even
now the prognosis must be guarded. Detection of the
causative mutation is important as it facilitates genetic
counselling of the parents and prenatal diagnosis in future
pregnancies.
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Computed tomography of the brain conducted at 5 weeks of  age showing an intra cerebral hemorrhage Figure 1
Computed tomography of the brain conducted at 5 weeks of 
age showing an intra cerebral hemorrhage.B
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Table 1: Cases of neonatal presentations of factor V deficiency reported in the English literature so far.
Age at first 
presentation
Birth 4 Days 10 days 18 Days Birth
Clinical presentation Hydrocephalus secondary to 
unilateral subdural 
hematoma
Large left subdural hematoma 
causing irritability, pallor, 
poor feeding
Antenatal diagnosis of increased 
head circumference and unilateral 
ventricular dilatation at 32/40, 
seizure on Day 10
Pallor, excessive crying, bleeding from 
umbilical stump, Large unilateral 
intracerebral bleed with intraventricular 
extension with hydrocephalus
Subdural hematoma
Family history Consanguineous parents, no 
bleeding diathesis in family
Nonconsanguineous parents, 
no bleeding diathesis in family
Nonconsanguineous parents, no 
bleeding diathesis in family
Consanguineous parents, no bleeding 
diathesis in family
Nonconsanginous, no bleeding 
diathesis in family
Clotting screen on 
presentation
PT: 33 (14)
PTT: 87 (33)
PT: Very high
PTT: immeasurable
PT: 61 s (31 s)
PTT: 178
Prothrombin ratio: 2.56 (Normal 1–1.2)
APTT: >200
PT: 58 s(control 8.7–11.5 s), APTT 
198.8 s (control: 29.5–42.7 s)
Factor V activity in baby 
(reference 70–120%)
< 1% < 5% 2% 3%
Presence of Factor 5 inhibitor 2.4 U
<0.4%
Factor V activity in 
parents
54%, 42% 35%, 40% 52%, 78% 40%, 63% 59%, 47%
Treatment Virus inactivated FFP Virus inactivated FFP FFP FFP, platelet concentrate, activated 
prothrombin complex, 
immunoglobulins, single-volume 
exchange transfusion
No data
Outcome Global neurodevelopemental 
delay
At 6 months, neurologically 
normal, but recurrent 
mucosal and soft tissue 
hemorhages
VA shunt to drain the 
hydrocephalus
VP shunt for hydrocephalus, death 
following another episode of 
intracranial bleed
No data
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